Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 6Not yet recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 155Neoplasms 113Carcinoma, Non-Small-Cell Lung 86Prostatic Neoplasms 84Colorectal Neoplasms 84Lung Neoplasms 72Carcinoma, Hepatocellular 51Leukemia, Myeloid, Acute 49Pancreatic Neoplasms 46Neoplasm Metastasis 41Multiple Myeloma 37Recurrence 35Triple Negative Breast Neoplasms 28Melanoma 28Squamous Cell Carcinoma of Head and Neck 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Ovarian Neoplasms 27Head and Neck Neoplasms 27Glioblastoma 27Brain Neoplasms 26Uterine Cervical Neoplasms 25Stomach Neoplasms 24Small Cell Lung Carcinoma 24Rectal Neoplasms 24Endometrial Neoplasms 21Carcinoma, Renal Cell 21Lymphoma, Follicular 20Lymphoma, B-Cell 19Lymphoma 19Motor Activity 17

Interventions

Vitamin D 1VP-102 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Warts × 90 days × Clear all
NCT07637734 2026-06-10

COVE-3

Verrica Pharmaceuticals Inc.

Phase 3 Not yet recruiting
300 enrolled

Warts

NCT07543926 2026-04-22

New Treatment of Common Wart

Sohag University

Phase NA Not yet recruiting
70 enrolled

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡